Intracellular thiol-rich metabolic proteins and macromolecules in hypoxic cells

Intracellular thiol-rich metabolic proteins and macromolecules refer to a broad class of sulfur-containing cellular components, such as glutathione (GSH) and various cysteine-rich enzymes, that are critical for maintaining redox balance (PMID: 11359128). In the hypoxic microenvironment of solid tumors, these molecules often serve as a protective buffer against oxidative stress and the reactive intermediates of certain chemotherapeutic agents (PMID: 10403104). This target classification is primarily associated with the pharmacology of bioreductive prodrugs like Tirapazamine, which are enzymatically reduced under low-oxygen conditions to form highly reactive radicals (PMID: 8401328). These radicals can either be scavenged by intracellular thiols, leading to their depletion, or they can attack essential macromolecules like DNA, resulting in double-strand breaks and cell death (PMID: 15173864). Consequently, the concentration and availability of these thiol-rich entities directly influence the therapeutic window and cytotoxic efficacy of hypoxia-selective drugs (PMID: 9726371). While not a single protein target, they represent a critical metabolic interface for drugs designed to exploit the unique chemical landscape of hypoxic cancer cells (PMID: 10903196).

Other names

Thiol-containing macromoleculesIntracellular thiolsCellular sulfhydryl groupsHypoxic cell thiolsRedox-active macromolecules

Bioreductive activation in hypoxic environments to form reactive radicals or electrophiles that interact with and are neutralized by intracellular thiols or cause damage to cellular macromolecules.